Skip to Main Content

The (POGO) Blog

February 12, 2013

By Andre Francisco

POGO's Staff Scientist Says New Doctor Rules Promote Transparency



Drug and FDA Issues New disclosure rules for doctors on advisory panels for the Food and Drug Administration are meant to increase transparency without discouraging doctors from serving on the panels, according to Ned Feder, POGO's staff scientist.

Continue Reading POGO's Staff Scientist Says New Doctor Rules Promote Transparency

Topics: Public Health and Science

February 4, 2013

By Andre Francisco

Government to Require Greater Doctor Payment Transparency



Drug and FDA Issues The federal government announced it would require drug and medical device makers to publicly disclose their payments to doctors and hospitals.

Continue Reading Government to Require Greater Doctor Payment Transparency

Topics: Public Health and Science

January 12, 2012

By Adam Zagorin

In Bed with Big Pharma? Industry Liaisons Raise Questions at the FDA



Photograph of an empty pack of birth control pills by "No comment." That's what the spokesman for a leading academic and member of a Food and Drug Administration (FDA) panel said when asked whether the member's ties to Bayer, the German drug giant, had "affected her judgment in any way regarding her vote o

Continue Reading In Bed with Big Pharma? Industry Liaisons Raise Questions at the FDA

Topics: Public Health and Science

Items 16 - 18 of 18  Previous1234

Browse POGOBlog by Topic

POGO on Facebook

POGOBlog Contributors

See All Blog Contributors

Latest Podcast

Podcast; Social Media, Internet Provides Opportunities, Challenges for Lawmakers

The Congressional Management Foundation offers the Gold Mouse Awards annually to members of Congress who make the most of the opportunity the digital world offers them. POGO spoke with members of Rep. Mike Honda's communications team about their award.